Retreatment with nivolumab for patients with recurrent and/or metastatic head and neck cancer. Wakasugi T, Takeuchi S, Ohkubo JI, Suzuki H, et al. Acta Otolaryngol 2022 Feb 11:1-7. doi: 10.1080/00016489.2022.2033317.

Read + Share

Amedeo Smart

Independent Medical Education

Wakasugi T, Takeuchi S, Ohkubo JI, Suzuki H, et al. Retreatment with nivolumab for patients with recurrent and/or metastatic head and neck cancer. Acta Otolaryngol 2022 Feb 11:1-7. doi: 10.1080/00016489.2022.2033317.
PMID: 35148228